BIOFIL CHEMICALS & PHARMACEUTICALS
|
The Current P/B Ratio of BIOFIL CHEMICALS & PHARMACEUTICALS is 6.38.
Share Price | ₹67.7 | May 03,2024 |
Market Cap | ₹110.3 Cr | |
Book Value | ₹17.3 Cr | Mar2023 - Standalone Results |
Price/Book | 6.38x | Calculated as MarketCap/Book Value |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PB (Price/Book ) ratio of BIOFIL CHEMICALS & PHARMACEUTICALS
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹110.3 Cr] as on May 03,2024
(/) Book Value [ ₹17.3 Cr] based on Mar2023 - Standalone Results
(=) P/B Ratio [ 6.38x ]
Thus, for BIOFIL CHEMICALS & PHARMACEUTICALS , the investors are currently willing to pay '6.38 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of BIOFIL CHEMICALS & PHARMACEUTICALS !
The chart below summarizes the trend in P/B Ratio of BIOFIL CHEMICALS & PHARMACEUTICALS over the last five years.
Historical PB (Price/Book ) ratio chart of BIOFIL CHEMICALS & PHARMACEUTICALS
PB Ratio Performance Analysis for BIOFIL CHEMICALS & PHARMACEUTICALS
- BIOFIL CHEMICALS & PHARMACEUTICALS 's p/b ratio for fiscal years ending Mar2023 to Mar2019 averaged 3.54x.
- BIOFIL CHEMICALS & PHARMACEUTICALS 's operated at median p/b ratio of 3.9x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, BIOFIL CHEMICALS & PHARMACEUTICALS 's p/b ratio peaked in Mar2021 at 6.62x.
- BIOFIL CHEMICALS & PHARMACEUTICALS 's p/b ratio hit its five-year low in Mar2019 of 0.79x.
How does BIOFIL CHEMICALS & PHARMACEUTICALS 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
---|---|---|---|
BIOFIL CHEMICALS & PHARMACEUTICALS | 17.30 | 6.38 | 110.3 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 55,995.40 | 6.46 | 361,916.0 |
CIPLA LTD | 23,346.00 | 4.93 | 115,034.0 |
DR REDDYS LABORATORIES LTD | 23,140.40 | 4.58 | 105,929.0 |
ZYDUS LIFESCIENCES LTD | 17,515.80 | 5.73 | 100,322.0 |
DIVIS LABORATORIES LTD | 12,767.10 | 8.21 | 104,873.0 |
MANKIND PHARMA LTD | 7,435.16 | 12.47 | 92,708.2 |
TORRENT PHARMACEUTICALS LTD | 6,198.07 | 14.92 | 92,483.6 |
LUPIN LTD | 12,315.60 | 6.13 | 75,438.0 |
AUROBINDO PHARMA LTD | 26,839.80 | 2.52 | 67,541.1 |
ABBOTT INDIA LTD | 3,146.02 | 17.66 | 55,555.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs BIOFIL CHEMICALS & PHARMACEUTICALS 's P/B Ratio
Top 10 Industry Peers | PB Ratio |
---|---|
Min industry PB | 2.52x |
Max industry PB | 17.66x |
Median industry PB | 6.38x |
Average industry PB | 8.18x |
You may also like the below Video Courses